Inotiv Inc (NOTV)
4.13
-0.16
(-3.73%)
USD |
NASDAQ |
Apr 26, 13:26
Inotiv Price to Book Value: 0.4191 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 25, 2024 | 0.4353 |
April 24, 2024 | 0.4739 |
April 23, 2024 | 0.4921 |
April 22, 2024 | 0.4485 |
April 19, 2024 | 0.4384 |
April 18, 2024 | 0.4769 |
April 17, 2024 | 0.55 |
April 16, 2024 | 0.5703 |
April 15, 2024 | 0.5713 |
April 12, 2024 | 0.6048 |
April 11, 2024 | 0.6687 |
April 10, 2024 | 0.7225 |
April 09, 2024 | 0.7499 |
April 08, 2024 | 0.7438 |
April 05, 2024 | 0.7245 |
April 04, 2024 | 0.7296 |
April 03, 2024 | 0.9599 |
April 02, 2024 | 0.963 |
April 01, 2024 | 1.002 |
March 28, 2024 | 1.110 |
March 27, 2024 | 1.081 |
March 26, 2024 | 1.019 |
March 25, 2024 | 1.120 |
March 22, 2024 | 1.080 |
March 21, 2024 | 1.015 |
Date | Value |
---|---|
March 20, 2024 | 0.9762 |
March 19, 2024 | 0.9173 |
March 18, 2024 | 0.9082 |
March 15, 2024 | 0.9265 |
March 14, 2024 | 0.8392 |
March 13, 2024 | 0.8402 |
March 12, 2024 | 0.8514 |
March 11, 2024 | 0.7742 |
March 08, 2024 | 0.8595 |
March 07, 2024 | 0.8067 |
March 06, 2024 | 0.8412 |
March 05, 2024 | 0.8108 |
March 04, 2024 | 0.7793 |
March 01, 2024 | 0.8108 |
February 29, 2024 | 0.756 |
February 28, 2024 | 0.6657 |
February 27, 2024 | 0.6707 |
February 26, 2024 | 0.6515 |
February 23, 2024 | 0.5662 |
February 22, 2024 | 0.6038 |
February 21, 2024 | 0.6058 |
February 20, 2024 | 0.6464 |
February 16, 2024 | 0.6068 |
February 15, 2024 | 0.5652 |
February 14, 2024 | 0.5794 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1619
Minimum
Nov 10 2023
70.28
Maximum
Jun 17 2021
6.437
Average
2.033
Median
Price to Book Value Benchmarks
Avid Bioservices Inc | 2.653 |
Macrogenics Inc | 5.944 |
Synlogic Inc | 0.5079 |
BioXcel Therapeutics Inc | -- |
IGM Biosciences Inc | 2.456 |
Price to Book Value Related Metrics
PS Ratio | 0.1817 |
Price to Free Cash Flow | 26.30 |
Price | 4.13 |
Earnings Yield | -31.48% |
Market Cap | 106.52M |
Operating PE Ratio | 19.49 |